Illumina Inc Net Income per Employee (ILMN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Illumina Inc   (NASDAQ: ILMN)
 

Illumina Inc Net Income per Employee

ILMN's Quarterly Results, Trends, Rankings, Statistics
Illumina Inc 's Income per employee fell in the second quarter 2026 on a trailing twelve month basis to $ 644,531, but the productivity of Illumina Inc 's 1,280 employees remained above the company average.
The Healthcare sector has seen Illumina Inc achieved the highest income per employee. While Illumina Inc 's total ranking has deteriorated compared to the previous quarter from 263 to 264.


What is Income per Employee Ratio?






ILMN Net Income per Employee (Jun 28 2026)
II. Quarter
(Mar 29 2026)
I. Quarter
(Dec 28 2025)
IV. Quarter
(Sep 28 2025)
III. Quarter
(Jun 29 2025)
II. Quarter
Y / Y Net Income Change -11.91 % 2.29 % 79.57 % -78.72 % -
Net Income per Employee (TTM) $ 644,531 666,406 664,063 548,438 982,031
ILMN's Total Ranking # 264 # 263 # 446 # 1053 # 635
Seq. Net Income Change 54.48 % -59.88 % 122.67 % -36.17 % 79.39 %


ILMN Net Income per Employee Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 39
Overall Market # 264

Net Income per Employee Statistics
High Average Low
$ 982,031 $ -60,987 $ -3,505,469
(Jun 29 2025)   (Apr 02 2023)







Companies with similar Income per Employee for 12 month ending Jun 28 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 28 2026Number of Employees Jun 28 2026
Tg Therapeutics Inc   1,106,491.23 $ 441.490  Million 399 
Halozyme Therapeutics Inc   977,768.32 $ 413.596  Million 423 
Zevra Therapeutics Inc   949,245.90 $ 57.904  Million 61 
Protagenic Therapeutics Inc new  910,314.00 $ 5.462  Million
Elite Pharmaceuticals Inc   871,814.86 $ 56.668  Million 65 
The Greater Cannabis Company Inc   740,754.00 $ 0.741  Million
Omeros Corporation  713,291.43 $ 124.826  Million 175 
Prestige Consumer Healthcare Inc   712,757.89 $ 406.272  Million 570 
Atlantic Coastal Acquisition Corp Ii  670,333.33 $ 2.011  Million
Illumina Inc   644,531.25 $ 825.000  Million 1,280 
Liquidia Corporation  641,694.44 $ 138.606  Million 216 
Harmony Biosciences Holdings inc   618,668.94 $ 181.270  Million 293 
Theravance Biopharma inc   597,866.67 $ 53.808  Million 90 
Vaxart Inc   593,676.92 $ 38.589  Million 65 
Glucotrack Inc   554,600.00 $ 8.319  Million 15 
Silexion Therapeutics Corp  489,714.29 $ 6.856  Million 14 
Sanuwave Health Inc   488,872.73 $ 26.888  Million 55 
Acadia Pharmaceuticals Inc   476,796.99 $ 380.484  Million 798 
Biolife Solutions Inc   374,070.97 $ 57.981  Million 155 
Neurocrine Biosciences Inc   352,750.00 $ 705.500  Million 2,000 


Date modified: 2026-08-30T22:16:52+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.